Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion

Affiliations

• ¹ University of Washington Medicine Diabetes Institute, Seattle, WA.
• ² Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
• ³ Diabetes Research Institute, University of Miami Health System, Miami, FL.
• ⁴ Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA.
• ⁵ College of Osteopathic Medicine, Touro University California, Vallejo, CA.